Tularemia: Mortality Risk, Treatment, and Prevention

Tularemia (Francisella tularensis) is a zoonotic bacterial infection with variable severity.

Mortality

  • Untreated: 5–15% (up to 30–60% for pneumonic/septicemic F. tularensis type A).
  • Treated promptly: <1% with appropriate antibiotics.

Clinical Forms

  • Ulceroglandular (most common): skin ulcer + regional lymphadenopathy
  • Glandular: lymphadenopathy without ulcer
  • Oculoglandular: conjunctivitis + preauricular nodes
  • Oropharyngeal: pharyngitis, cervical nodes
  • Pneumonic: inhalation → pneumonia, high mortality
  • Typhoidal: systemic, no localizing signs

Treatment

  • First-line: Streptomycin 1 g IM q12h × 10–14 d (gold standard) OR gentamicin 5 mg/kg IV/IM daily × 10 d.
  • Alternatives: Doxycycline 100 mg BID × 14–21 d (bacteriostatic, higher relapse); ciprofloxacin (adults).
  • Meningitis: Combination therapy + expert ID consult.

Prevention

  • Tick/insect repellent (DEET, permethrin clothing)
  • Gloves when handling rabbits/rodents
  • Cook game meat thoroughly
  • Lab safety: BSL-3 for F. tularensis (Category A biothreat agent)

Early diagnosis (serology, PCR, culture) and aminoglycoside therapy are lifesaving.

Blood Disorders - Related Articles